FAN
EW icon

Financial Advisors Network’s Edwards Lifesciences EW Stock Holding History

Financial Advisors Network’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87M Buy
35,794
+3,227
+10% +$266K 0.4% 41
2025
Q4 		$2.78M Buy
32,567
+8,707
+36% +$715K 0.38% 49
2025
Q3 		$1.86M Buy
23,860
+3,071
+15% +$240K 0.26% 62
2025
Q2 		$1.63M Buy
20,789
+845
+4% +$63K 0.25% 62
2025
Q1 		$1.45M Buy
19,944
+355
+2% +$25.4K 0.24% 63
2024
Q4 		$1.45M Buy
+19,589
New +$1.37M 0.24% 61
2023
Q4 		$1.23M Hold
16,148
– – 0.25% 54
2023
Q3 		$1.12M Buy
+16,148
New +$1.3M 0.25% 52
2022
Q4 		$1.17M Buy
15,721
+2,847
+22% +$219K 0.31% 49
2022
Q3 		$1.06M Buy
12,874
+157
+1% +$15.1K 0.31% 48
2022
Q2 		$1.21M Sell
12,717
-84
-0.7% -$8.7K 0.34% 47
2022
Q1 		$1.51M Sell
12,801
-426
-3% -$47.8K 0.37% 45
2021
Q4 		$1.71M Buy
13,227
+1,133
+9% +$132K 0.39% 46
2021
Q3 		$1.4M Sell
12,094
-35
-0.3% -$4K 0.32% 48
2021
Q2 		$1.26M Sell
12,129
-302
-2% -$28.5K 0.37% 48
2021
Q1 		$1.04M Hold
12,431
– – 0.34% 51
2020
Q4 		$1.13M Hold
12,431
– – 0.39% 45
2020
Q3 		$992K Hold
12,431
– – 0.39% 45
2020
Q2 		$859K Buy
12,431
+1,196
+11% +$85K 0.35% 47
2020
Q1 		$706K Hold
11,235
– – 0.34% 47
2019
Q4 		$874K Hold
11,235
– – 0.4% 48
2019
Q3 		$824K Hold
11,235
– – 0.42% 46
2019
Q2 		$798K Hold
11,235
– – 0.43% 45
2019
Q1 		$639K Sell
11,235
-270
-2% -$15.4K 0.37% 52
2018
Q4 		$587K Buy
+11,505
New +$582K 0.37% 57
2018
Q2 		$551K Buy
+11,355
New +$530K 0.33% 57
2017
Q4 		$448K Buy
11,934
+24
+0.2% +$881 0.3% 68
2017
Q3 		$434K Hold
11,910
– – 0.34% 57
2017
Q2 		$469K Buy
+11,910
New +$435K 0.39% 49
2017
Q1 		– Sell
-78
Closed -$2.51K – 207
2016
Q4 		$2.51K Buy
+78
New +$2.53K ﹤0.01% 412

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Financial Advisors Network's EW Position: Q1 2026 in Review

Financial Advisors Network increased its Edwards Lifesciences (EW) stake by 9.9% in Q1 2026, buying an estimated $266K and bringing the position to 35,794 shares worth $2.87M. The position accounts for 0.4% of the portfolio, ranked #41.

Financial Advisors Network first reported a position in EW in Q4 2016 and has held it in 30 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Financial Advisors Network held 35,794 shares of Edwards Lifesciences worth $2.87M as of Q1 2026.
  • Financial Advisors Network bought 3,227 Edwards Lifesciences shares in Q1 2026, an estimated $266K.
  • Edwards Lifesciences made up 0.4% of Financial Advisors Network's portfolio in Q1 2026, its #41 holding.
  • Financial Advisors Network first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 30 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Financial Advisors Network's 13F filing for Q1 2026, filed 15 May 2026.